Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Topic: Brain proteins, microglia and lab models

Heterozygous, loss-of-function mutations in the granulin gene (GRN) encoding progranulin (PGRN) are a common cause of frontotemporal dementia (FTD). Homozygous GRN mutations cause neuronal ceroid lipofuscinosis-11 (CLN11), a lysosome storage disease. PGRN is a secreted glycoprotein that can be proteolytically cleaved into seven bioactive 6 kDa granulins. However, it is unclear how deficiency of PGRN and granulins causes neurodegeneration. To gain insight into the mechanisms of FTD pathogenesis, we utilized Tandem Mass Tag isobaric labeling mass spectrometry to perform an unbiased quantitative proteomic analysis of whole-brain tissue from wild type (Grn +/+ ) and Grn knockout (Grn -/- ) mice at 3- and 19-months of age. At 3-months lysosomal proteins (i.e. Gns, Scarb2, Hexb) are selectively increased indicating lysosomal dysfunction is an early consequence of PGRN deficiency. Additionally, proteins involved in lipid metabolism (Acly, Apoc3, Asah1, Gpld1, Ppt1, and Naaa) are decreased; suggesting lysosomal degradation of lipids may be impaired in the Grn -/- brain. Systems biology using weighted correlation network analysis (WGCNA) of the Grn -/- brain proteome identified 26 modules of highly co-expressed proteins. Three modules strongly correlated to Grn deficiency and were enriched with lysosomal proteins (Gpnmb, CtsD, CtsZ, and Tpp1) and inflammatory proteins (Lgals3, GFAP, CD44, S100a, and C1qa). We find that lysosomal dysregulation is exacerbated with age in the Grn -/- mouse brain leading to neuroinflammation, synaptic loss, and decreased markers of oligodendrocytes, myelin, and neurons. In particular, GPNMB and LGALS3 (galectin-3) were upregulated by microglia and elevated in FTD-GRN brain samples, indicating common pathogenic pathways are dysregulated in human FTD cases and Grn -/- mice. GPNMB levels were significantly increased in the cerebrospinal fluid of FTD-GRN patients, but not in MAPT or C9orf72 carriers, suggesting GPNMB could be a biomarker specific to FTD-GRN to monitor disease onset, progression, and drug response. Our findings support the idea that insufficiency of PGRN and granulins in humans causes neurodegeneration through lysosomal dysfunction, defects in autophagy, and neuroinflammation, which could be targeted to develop effective therapies.

Key findings

• GPNMB levels were significantly increased in the cerebrospinal fluid of FTD-GRN patients, but not in MAPT or C9orf72 carriers, suggesting GPNMB could be a biomarker specific to FTD-GRN to monitor disease onset, progression, and drug response.
• Our findings support the idea that insufficiency of PGRN and granulins in humans causes neurodegeneration through lysosomal dysfunction, defects in autophagy, and neuroinflammation, which could be targeted to develop effective therapies.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1186/s40478-020-01037-x
• PubMed: 33028409
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{huang2020-33028409,
  author  = {Huang, M. and Modeste, E. and Dammer, E. and Merino, P. and Taylor, G. and Duong, D. M. and Deng, Q. and Holler, C. J. and others},
  title   = {{Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations}},
  journal = {Acta neuropathologica communications},
  year    = {2020},
  doi     = {10.1186/s40478-020-01037-x},
  pmid    = {33028409},
  url     = {https://doi.org/10.1186/s40478-020-01037-x}
}

Related studies in Disease mechanisms

• Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability Stem cell reports · 2016-09-01 · usefulness score 40/100
• Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America · 2010-07-26 · usefulness score 36/100
• Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease Cell reports. Medicine · 2020-11-17 · usefulness score 50/100
• Synaptic dysfunction in progranulin-deficient mice Neurobiology of disease · 2011-10-25 · usefulness score 36/100
• Integrative Multiomics Analysis Reveals a Coordinated Molecular Signature of Neuroresilience in human MAPT-knockout hiPSC-derived Neurons with relevance for Alzheimer’s and Neurodegenerative Disease Research Square · 2026-10-14 · usefulness score 16/100
• Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review Alzheimer's research & therapy · 2018-01-09 · usefulness score 51/100

Also tagged “mice”

1,150 studies in the library carry the topic tag “mice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

• Stress-Specific Mitochondrial Reserve as a Candidate Modifier of Lipid-Driven Synaptic Failure in Alzheimer Disease Zenodo (CERN European Organization for Nuclear Research) · 2026-08-08 · usefulness score 66/100 · Treatments
• Endoplasmic reticulum stress mediates amyloid β neurotoxicity via mitochondrial cholesterol trafficking The American journal of pathology · 2014-05-09 · usefulness score 45/100 · Risk genes beyond APOE
• Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance The Journal of biological chemistry · 2010-05-14 · usefulness score 44/100 · Risk genes beyond APOE

Similar studies

• Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia 2010 · Inflammation and the immune system
• Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic 2021 · Inflammation and the immune system
• Frontotemporal dementia as a consequence of GRN mutations: From disease cause to models to therapies 2025 · Lewy body dementia
• Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice 2010 · Lewy body dementia
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 2006 · Lewy body dementia
• Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis 2018 · Inflammation and the immune system

More on Disease mechanisms

• A review that covers this ground Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature Acta neuropathologica communications · 2021-06-29 · usefulness score 59/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →